Comparative Study of Three NNRTI-Sparing HAART Regimens

NCT00811954 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1814

Enrollment

NETWORK

Sponsor class

Conditions

HIV Infection

Interventions

DRUG: Emtricitabine/tenofovir disoproxil fumarate
DRUG: Raltegravir
DRUG: Darunavir
DRUG: Ritonavir
DRUG: Atazanavir

Sponsor

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]